Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.

Bukirwa H, Unnikrishnan B, Kramer CV, Sinclair D, Nair S, Tharyan P.

Cochrane Database Syst Rev. 2014 Mar 4;3:CD006404. doi: 10.1002/14651858.CD006404.pub2. Review.

2.

WITHDRAWN: Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Effa EE, Bukirwa H.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD006083. doi: 10.1002/14651858.CD006083.pub3. Review.

PMID:
21975751
3.

Assessing rapid diagnostic tests for malaria.

Bukirwa H.

Cochrane Database Syst Rev. 2011 Jul 26;(9):ED000031. doi: 10.1002/1305223.ED000031. No abstract available.

PMID:
21901735
4.

Improved malaria case management through the implementation of a health facility-based sentinel site surveillance system in Uganda.

Sserwanga A, Harris JC, Kigozi R, Menon M, Bukirwa H, Gasasira A, Kakeeto S, Kizito F, Quinto E, Rubahika D, Nasr S, Filler S, Kamya MR, Dorsey G.

PLoS One. 2011 Jan 19;6(1):e16316. doi: 10.1371/journal.pone.0016316.

5.

Heterogeneities and consequences of Plasmodium species and hookworm coinfection: a population based study in Uganda.

Pullan RL, Kabatereine NB, Bukirwa H, Staedke SG, Brooker S.

J Infect Dis. 2011 Feb 1;203(3):406-17. doi: 10.1093/infdis/jiq063. Epub 2010 Dec 27.

6.

Heritability of Plasmodium parasite density in a rural Ugandan community.

Pullan RL, Bukirwa H, Snow RW, Brooker S.

Am J Trop Med Hyg. 2010 Nov;83(5):990-5. doi: 10.4269/ajtmh.2010.10-0049.

7.

Plasmodium infection and its risk factors in eastern Uganda.

Pullan RL, Bukirwa H, Staedke SG, Snow RW, Brooker S.

Malar J. 2010 Jan 4;9:2. doi: 10.1186/1475-2875-9-2.

8.

Assessing the impact of indoor residual spraying on malaria morbidity using a sentinel site surveillance system in Western Uganda.

Bukirwa H, Yau V, Kigozi R, Filler S, Quick L, Lugemwa M, Dissanayake G, Kamya M, Wabwire-Mangen F, Dorsey G.

Am J Trop Med Hyg. 2009 Oct;81(4):611-4. doi: 10.4269/ajtmh.2009.09-0126.

9.

Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children.

Jensen TP, Bukirwa H, Njama-Meya D, Francis D, Kamya MR, Rosenthal PJ, Dorsey G.

Malar J. 2009 Sep 15;8:213. doi: 10.1186/1475-2875-8-213.

10.

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.

Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M.

Malar J. 2009 Aug 23;8:203. doi: 10.1186/1475-2875-8-203.

11.

Improved malaria case management after integrated team-based training of health care workers in Uganda.

Ssekabira U, Bukirwa H, Hopkins H, Namagembe A, Weaver MR, Sebuyira LM, Quick L, Staedke S, Yeka A, Kiggundu M, Schneider G, McAdam K, Wabwire-Mangen F, Dorsey G.

Am J Trop Med Hyg. 2008 Dec;79(6):826-33.

12.

Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Effa EE, Bukirwa H.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006083. doi: 10.1002/14651858.CD006083.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(10):CD006083.

PMID:
18843701
13.

Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.

Ashley EA, Pinoges L, Turyakira E, Dorsey G, Checchi F, Bukirwa H, van den Broek I, Zongo I, Urruta PP, van Herp M, Balkan S, Taylor WR, Olliaro P, Guthmann JP.

Malar J. 2008 Aug 9;7:154. doi: 10.1186/1475-2875-7-154.

14.

Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Bukirwa H, Nayiga S, Lubanga R, Mwebaza N, Chandler C, Hopkins H, Talisuna AO, Staedke SG.

Trop Med Int Health. 2008 Sep;13(9):1143-52. doi: 10.1111/j.1365-3156.2008.02119.x. Epub 2008 Jul 8.

15.

Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.

Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO.

Malar J. 2008 Jun 11;7:107. doi: 10.1186/1475-2875-7-107.

16.

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.

Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H.

PLoS One. 2008 Jun 11;3(6):e2390. doi: 10.1371/journal.pone.0002390.

17.

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial.

Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, Wabwire-Mangen F, Dorsey G.

PLoS Clin Trials. 2007 May 18;2(5):e20.

18.

Access to electronic health knowledge in five countries in Africa: a descriptive study.

Smith H, Bukirwa H, Mukasa O, Snell P, Adeh-Nsoh S, Mbuyita S, Honorati M, Orji B, Garner P.

BMC Health Serv Res. 2007 May 17;7:72.

19.

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, Rwakimari JB, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, Staedke SG.

PLoS Clin Trials. 2006 May;1(1):e7. Epub 2006 May 19.

20.

Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.

Bukirwa H, Critchley J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004966. Review.

PMID:
16437507
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk